Skip to content
Recall Observatory FDA recall evidence

Drug product

Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01

D-0535-2025

July 09, 2025

Class II

Product summary

Firm
Imprimis NJOF, LLC
Event
Event 97183
Status
Completed
Classification
Class II
Quantity
6,880 vials
Official record key
drug-enforcement:D-0535-2025

Official wording

Reason: Sub-Potent Drug: Subpotent assay results during stability testing.

Code information: Lot: 24DEC017, Exp. 07/12/2025.

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent